Epidermal growth factor and heregulin effect on breast cancer cell line: dose response and time course
Analysis of MCF-7 breast cancer cells treated with various doses of epidermal growth factor (EGF) or heregulin (HRG) for up to 90 minutes. EGF and HRG induce distinct kinase kinetics and phenotypes of MCF-7 cells. Results provide insight into the linkage between signaling dynamics and cell fate.
Cancer Type: Breast Cancer
GPL: 571
Number of Genes with Data: 939
Number Observations: 57
Number Outputs: 1
Imbalanced Ratio: 0.071428571
Default Task: Classification